Title: Attenuation of doxorubicin cardiotoxicity and NADPH oxidase activation by the AT1 receptor antagonist, losartan. Abstract: (Your abstract must use 10pt Arial font and must not be longer than this box) The use of d - Antagonist - Document - PDFSEARCH.IO

First Page	Meta Content
	Title: Attenuation of doxorubicin cardiotoxicity and NADPH oxidase activation by the AT1 receptor antagonist, losartan. Abstract: (Your abstract must use 10pt Arial font and must not be longer than this box) The use of d Add to Reading List Document Date: 2014-07-28 07:23:19 Open Document File Size: 136,75 KB Share Result on Facebook MedicalCondition DOX-induced cardiac dysfunction / / MedicalTreatment catheterization / chemotherapy / / Position author / / Product losartan / / Technology chemotherapy / / SocialTag Alcohols Imidazoles Losartan Organochlorides Tetrazoles Dox Angiotensin II receptor antagonist NADPH oxidase Heart failure Chemistry

Title: Attenuation of doxorubicin cardiotoxicity and NADPH oxidase activation by the AT1 receptor antagonist, losartan. Abstract: (Your abstract must use 10pt Arial font and must not be longer than this box) The use of dAdd to Reading List